Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 A.m. ET on July 31, 2024

Yahoo FinanceJul 2 18:00 ET

New AJOVY (Fremanezumab) Migraine Prevention Data Challenges Treatment Pauses

Yahoo FinanceJun 28 11:30 ET

Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020

Yahoo FinanceJun 25 08:00 ET

Form 144 | Teva Pharmaceutical Industries(TEVA.US) Insider Proposes to Sell 8.89 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 18, $Teva Pharmaceutical Industries(TEVA.US)$、$TEVA PHARMACEUTICAL INDUSTRIES(TEVJF.US)$ Insider Bridger Management, LLC (1) intends to sell 519K shares of its common stock

moomoo NewsJun 18 16:18 ET

Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)

Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)

Earnings Call TranscriptsJun 11 11:41 ET

Barclays Adjusts Price Target on Teva Pharmaceutical Industries to $21 From $20, Maintains Overweight Rating

Teva Pharmaceutical Industries (TEVA) has an average outperform rating and price target range of $14.50 to $22, according to analysts polled by Capital IQ. Price: 16.76, Change: +0.13, Percent Change:

MT NewswiresJun 5 11:35 ET